Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/inderscience-publishers/financing-forefront-technology-entrepreneurship-issues-concerning-QbKPJfEICJ
References (21)
-
Yali Friedman (2008)
The Business of Biotechnology -
(1983)
Financial Issues in Biotechnology, Contract Report Prepared for the Office of Technology Assessment, US Congress, March -
(2003)
Company and public institution business strategies in the biotechnology arena’, Presented in the 12th International Conference of the International Association for Management -
(1986)
RDLPs soon to become financial dinosaurs -
(1990)
Partnerships and tax shelters: an analysis of the impact of the 1986 tax reform -
D. Merrifield (1986)
R&D Limited Partnerships Are Starting To Bridge the Invention-Translation GapResearch management, 29
-
V. Moses, R. Cape (1991)
Biotechnology: The Science and the Business -
(2006)
Special deals bring value to biotech -
(1990)
Units Offerings as an Off-Balance-Sheet Financing Mechanism for High Risk R and D, Working Paper, Santa Clara University, June -
(2006)
Biotech’s Financial Lifeline, April, Forbes.com -
A. Aguilar, T. Ingemansson, S. Hogan, E. Magnien (1998)
Industrial platforms--a unique feature of the European Commission's biotechnology R&D programme.Trends in biotechnology, 16 9
-
Arthur Klausner (1987)
Japanese Biotech: The Good with the BadBio/Technology, 5
-
(1988)
‘ Where are the Japanese biotechnology start - ups ? -
(2005)
An analysis of the first strategic merger in the early phase of the biotechnogenetic revolution. The Chiron-Cetus case -
J. Warner (1989)
A marriage of convenience or necessity?Nature, 338
-
(2005)
From scientific research to technology design. An analysis of issues concerning the DNA-RNA theoretical area -
(2003)
The role of small dedicated firms in the starting phase of the biotechnogenetic revolution -
Lee Knight, R. Knight (1997)
What Happened to Limited PartnershipsJournal of accountancy, 184
-
Michael Mihalka (1996)
A marriage of convenienceHelsinki Monitor, 7
-
(1988)
Strategie di Avviamento di Settori Industriali alle Frontiere della Tecnologia -
(1987)
Biotechnology firms need tax strategies that address key issues
- Publisher
- Inderscience Publishers
- Copyright
- Copyright © Inderscience Enterprises Ltd. All rights reserved
- ISSN
- 1746-5370
- eISSN
- 1746-5389
- DOI
- 10.1504/IJTE.2009.027543
- Publisher site
- See Article on Publisher Site
Abstract
This paper surveys financial issues that characterise the US biotechnology scenario. They regard public institutions and companies. The financing approaches available to New Biotechnology Firms (NBFs) force them to operate in a weak competitive position vis-?-vis large companies. Allowing NBFs to somewhat uncouple their investment decisions from the impact on company balance sheet, could give a fundamental contribution to enhance their competitive capacity and fully exploit their potential. The scheme of an off-balance-sheet financing is proposed. It is of the type that regulated the Research and Development Project Limited Partnership (RDLP) in the USA till 1986 when its tax benefits were cancelled by the Tax Reform Act. After 1986, NBFs have proposed to financial markets substitutes for RDLPs, which have proved to be much less interesting to investors. Restoring the rules originally governing RDLPs could be a strategically winning move at the present stage of the biotechogenetic revolution in the USA. An earlier and shorter version of this paper was presented by the author at the Unido sponsored 14th International Conference on Management of Technology, track 12 The Integration of Technology and Business Strategies, IAMOT 2005, Vienna, Austria, May 2005.
Journal
International Journal of Technoentrepreneurship – Inderscience Publishers
Published: Jan 1, 2009